Specialized immune cells help our skin respond to changing environmental conditions
These immune cells, which occupy the epithelial layers between the skin surface and its stem cells, act as a system regulator.
As the steadfast protector of the body’s interior, the skin must be able to swiftly respond to stressors from the outside world and then return to a steady state in order to maintain everyday operations. Coordinating that agile response are epidermal stem cells, which produce the overlying protective layers of specialized skin cells sent to the surface while also maintaining a ready pool of new stem cells to draw from.
The mechanisms that regulate this system to constantly maintain a normal flux have long remained elusive. Now researchers at Rockefeller University have discovered a regulatory circuit connecting the skin surface to stem cells via Langerhans immune cells, whose cellular projections span the epithelial layers and transmit signals between the two, that acts as a system regulator. They published their results in Science.
“This circuit acts like a rheostat that continuously fine tunes the stem cells’ response to the environment at the skin surface,” says first author Anita Gola, a research associate in the Robin Chemers Neustein Laboratory of Mammalian Cell Biology and Development, led by Elaine Fuchs. “Langerhans cells pick up signals from microbes on the skin surface and, through chemical messaging, signal to stem cells whether they need to produce new stem cells or direct cells to differentiate.”
“Essentially, Langerhans cells act as liaisons to regulate host-microbe interactions, while joining forces with the stem cells to maintain the integrity and antimicrobial peptide production of the skin’s barrier,” Fuchs says.
Seeking the system
Fuchs’s lab has already discovered epidermal circuits that operate in response an acute inflammation and wound repair, and that allow the skin to mount and retain epigenetic memories of its past experiences. Here, they set out to find another unknown mechanism: the communication system linking epidermal stem cells to signals coming from microbes on the body surface, which enables dynamic responses to ever-changing environmental factors.
They suspected the signaling network involved nearby cells in the local “niche”—a kind of cellular and physical neighborhood—and within this niche in mouse skin there were only two potential candidates: dendritic epithelial T cells (DETCs), a type of specialized lymphocyte, and Langerhans cells (LCs), a classic antigen-presenting cell, known to be a central player in driving adaptive immune responses in lymph nodes. Much of this view traces back to Rockefeller’s Ralph Steinman, whose pioneering work established LCs as members of the dendritic cell family; Steinman was awarded the 2011 Nobel Prize for his discovery of dendritic cells and their role in adaptive immunity.
They leaned towards LCs, which concentrate in vulnerable barrier areas such as the skin, mouth, and nose. “We know that macrophages in general are highly sensitive to their local environment and often have embedded functions that maintain their niches, so we wondered whether Langerhans cells, which spend their lives in sustained contact with epidermal stem cells and can extend their dendrites right through the skin’s epithelial layers, might have additional, stem cell regulatory roles beyond their well-appreciated immunological ones,” says Gola.
Keeping stem cells in check
Using genetic LC knockout approaches in a series of in vivo experiments, the Fuchs lab found that animals lacking LCs showed increased epidermal stem-cell proliferation and differentiation. “This suggested that the stem cell compartment wasn't behaving exactly as it should in a homeostatic condition,” Gola says. ”That was our first smoking gun.”
By probing gene expression in these cells, they found a gene called Ptgs1 was uniquely enriched in Langerhans cells when compared to all other skin resident immune cells. The gene codes for the enzyme COX-1, which is essential for the production of prostaglandins, a class of hormone-like lipid mediators involved in a multitude of cellular functions. In Langerhans cells, the high expression of COX-1 led to the robust production of a type of prostaglandin called PGE2. They then discovered that epidermal stem cells have only one prostaglandin receptor— EP4, and it’s the one specific for PGE2.
Further experiments revealed what happens when there isn’t enough PGE2 for the stem cells: “Without this brake on proliferation, stem cell proliferation increases,” says Fuchs. “Their progeny don’t completely finish differentiating before reaching the skin surface, which means that they can’t perform quite as well the tasks they’re supposed to do. It’s like sending in a team of amateurs to do work that requires professional expertise.”
That incomplete development led to specific problems. “We found that immature epithelial cells had extreme responses to benign bacteria that would normally reside on mouse skin without issue,” Gola notes. “We also saw structural weakening of the skin barrier, an overgrowth of different types of native bacteria, and a decrease in the amount of antimicrobial peptides that the skin should make to maintain a healthy microbiota.”
The presence of Langerhans cells prevented these negative outcomes. “They’re attuned to signals from microbiota at the surface and adjust production of PGE2 and the levels of COX-1 enzyme in response to those signals, which puts the brakes on epidermal stem cell proliferation by suppressing a signaling pathway associated with cell division,” she says. “Simultaneously, they promote the production of differentiated cells.”
“We think that there is some redundancy in the system, so it could be that this COX-1 prostaglandin regulator integrates multiple signals upstream,” Gola says.
Pathogens and inflammation
“Anita did such a beautiful job of sleuthing out this circuit step by step and demonstrating that the circuit is constantly being fine tuned to respond to an ever-changing suite of stressors,” Fuchs says. “Even something as mundane as washing your hands may require this type of fine-tuned regulation to help the skin barrier maintain homeostasis.”
The researchers theorize that because the cycle of response and reset is so essential to protecting the skin barrier, this system may integrate a number of signals to maintain local skin fitness. Looking forward, the Fuchs lab is excited to now explore how Langerhans cells respond to negative inputs such as pathogenic bacteria and inflammation.
Journal
Science
Article Title
A commensally regulated immune rheostat fine-tunes skin barrier fitness
Article Publication Date
29-Oct-2026
Could a few bad dietary choices worsen your next immune response?
University of California - San Francisco
Scientists have long known that diet shapes the immune system. Now, a UC San Francisco team has found that even a brief dietary change can substantially change how the body responds to skin irritation, at least in mice.
When scientists fed mice a high-fat diet for just a few days, the mice had a much worse reaction to an irritating cream. And the skin stayed on alert even after the mice returned to a low-fat diet and the inflammation cleared, responding more strongly the next time it was exposed to the cream.
The findings suggest that short-term diet may have just as much an effect as body weight when it comes to inflammation.
“Long-term dietary habits absolutely matter for health, but our study unearthed a much more real-time influence of diet,” said Sagar Bapat, MD, PhD, professor of pathology at UCSF and corresponding author of the paper, which appears in Nature on October 28. “Breakfast, lunch, dinner — they all can have a tremendous and rapid impact on the immune system.”
The discovery grew from laboratory experiments on obesity, led by Zewen “Owen” Jiang, PhD, co-first author of the paper, carried out when he was a graduate student at UCSF.
Jiang and his colleagues first raised mice on either low-fat or high-fat food pellets. Then, the scientists applied imiquimod, a cream that triggers skin inflammation, to one ear of each mouse and compared what happened between the low- or high-fat diet groups.
Obese mice habitually fed high-fat pellets had severe reactions to imiquimod, while mice fed with low-fat pellets had mild reactions.
“For many years, we’ve known that obesity is tied to more severe inflammation. But we wanted to know whether it was the extra weight or simply the bad diet that was driving the stronger response,” Jiang said.
So, the team tested whether just four days on high-fat food was enough to trigger an over-active immune response. They switched mice that had been raised on low-fat food to high-fat food, and dabbed one ear with imiquimod three days later. The normal-weight mice developed severe ear inflammation just like the obese mice.
Likewise, obese mice that had been switched to normal food for just four days experienced much milder inflammation.
Weeks later, after the normal-weight mice had returned to a low-fat diet and their inflammation had subsided, they got a second dose of imiquimod in the same ear that had flared before — and it triggered an outsized response.
Jiang and Bapat found that high-fat food drew rapid-response immune cells into the skin, where they amplified the reaction to imiquimod. As the inflammation subsided, other immune cells, called memory T cells remained in the affected ear. Together, these changes left the tissue primed for the next time.
The team found a similar kind of heightened inflammation in response to irritation in the lungs after just a few days of eating a high-fat diet.
“The diet of a laboratory mouse doesn’t map neatly onto what we eat, but it’s striking how quickly the immune system responds to what’s happening in the body right now,” said Jiang. “Diet, exercise, sleep — they could all shape immune health in ways we don’t yet appreciate.”
Authors: Other UCSF authors are John M. Tayeri; Im-Hong Sun, PhD; Joy Li, PhD; E. Dean Merrill, MD; Longhui Qiu; Dongliang Zhang, MD; Vrinda Johri; Megan E. Dobson, PhD; Ruriko Watanabe, PhD; Mazharul Maishan; Margaret M. Lowe, PharmD, PhD; Chihiro Tabuchi, PhD; Sarah G. Gayer; Arum Yoo; Nandini Borkar; Jiaxi Wang; Han Yin; Shin Shyan Chuah; Preetal Deshpande; Brittany Davidson; Jessica Tsui; Nicholas F. Kuhn, PhD; Tristan Courau, PhD; Vinh Q. Nguyen; Raymond J. Cho, MD, PhD; Jeffrey B. Cheng, MD; Michael D. Rosenblum, MD, PhD; Mark R. Looney, MD; Alexis J. Combes, PhD; Ari B. Molofsky, MD, PhD; Michael A. Matthay, MD; and James M. Gardner, MD, PhD. For all authors, see the paper.
Funding: This work was supported in part by the National Institutes of Health (R01DK125260, P30DK116074, R35HL161241, R38HL143581, K38HL154202). For all funding and disclosures, see the paper.
About UCSF: The University of California, San Francisco (UCSF) is exclusively focused on the health sciences and is dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. UCSF Health, which serves as UCSF’s primary academic medical center, includes top-ranked specialty hospitals and other clinical programs, and has affiliations throughout the Bay Area. UCSF School of Medicine also has a regional campus in Fresno. Learn more at ucsf.edu or see our Fact Sheet.
###
Follow UCSF
ucsf.edu | Facebook.com/ucsf | Twitter.com/ucsf | YouTube.com/ucsf
Journal
Nature